tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market

Chugai Pharmaceutical Co (CHGCF) Ratios

Compare
22 Followers

Chugai Pharmaceutical Co Ratios

CHGCF's free cash flow for Q3 2025 was ¥0.70. For the 2025 fiscal year, CHGCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.68 5.53 4.74 3.15 3.25
Quick Ratio
4.75 4.70 3.79 2.46 2.61
Cash Ratio
1.71 1.86 1.59 0.52 0.82
Solvency Ratio
1.43 1.37 1.16 0.91 0.95
Operating Cash Flow Ratio
1.54 1.54 1.42 0.58 0.85
Short-Term Operating Cash Flow Coverage
0.00 70.32 0.00 0.00 0.00
Net Current Asset Value
¥ 1.22T¥ 1.30T¥ 1.06T¥ 891.17B¥ 712.98B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.16 1.16 1.19 1.31 1.30
Debt Service Coverage Ratio
7.23K 64.87 0.00 6.65K 6.96K
Interest Coverage Ratio
10.02K 5.73K 0.00 8.74K 8.79K
Debt to Market Cap
0.00 <0.01 0.00 0.00 0.00
Interest Debt Per Share
7.39 6.68 8.18 8.62 9.78
Net Debt to EBITDA
-0.77 -0.92 -0.94 -0.37 -0.56
Profitability Margins
Gross Profit Margin
69.48%70.97%62.81%62.20%66.18%
EBIT Margin
45.60%46.40%39.94%42.33%41.95%
EBITDA Margin
47.43%49.10%42.80%44.66%45.04%
Operating Profit Margin
47.90%46.46%39.52%42.33%42.20%
Pretax Profit Margin
45.60%46.39%39.93%42.16%41.95%
Net Profit Margin
32.73%33.09%29.29%29.72%30.31%
Continuous Operations Profit Margin
32.72%33.09%29.29%29.72%30.31%
Net Income Per EBT
71.77%71.32%73.33%70.49%72.25%
EBT Per EBIT
95.18%99.84%101.06%99.60%99.40%
Return on Assets (ROA)
18.19%17.54%16.84%20.03%19.69%
Return on Equity (ROE)
20.68%20.37%20.02%26.29%25.50%
Return on Capital Employed (ROCE)
30.34%28.36%26.71%36.88%34.83%
Return on Invested Capital (ROIC)
21.78%20.16%19.59%26.00%25.16%
Return on Tangible Assets
18.48%17.68%17.02%20.30%19.98%
Earnings Yield
2.86%3.36%3.70%6.76%4.93%
Efficiency Ratios
Receivables Turnover
3.43 3.50 3.49 2.46 2.81
Payables Turnover
4.70 21.05 7.62 2.27 2.22
Inventory Turnover
1.50 1.42 1.51 1.63 1.62
Fixed Asset Turnover
2.62 2.65 2.64 3.26 2.84
Asset Turnover
0.56 0.53 0.58 0.67 0.65
Working Capital Turnover Ratio
0.93 0.98 1.12 1.53 1.50
Cash Conversion Cycle
271.39 344.71 298.35 211.61 191.04
Days of Sales Outstanding
106.41 104.22 104.73 148.48 129.97
Days of Inventory Outstanding
242.71 257.82 241.52 223.95 225.42
Days of Payables Outstanding
77.74 17.34 47.90 160.82 164.36
Operating Cycle
349.13 362.05 346.25 372.43 355.40
Cash Flow Ratios
Operating Cash Flow Per Share
250.23 271.99 249.16 148.41 170.07
Free Cash Flow Per Share
214.24 241.05 204.03 105.10 125.75
CapEx Per Share
35.98 30.95 45.14 43.31 44.32
Free Cash Flow to Operating Cash Flow
0.86 0.89 0.82 0.71 0.74
Dividend Paid and CapEx Coverage Ratio
1.15 2.43 1.99 1.17 1.63
Capital Expenditure Coverage Ratio
6.95 8.79 5.52 3.43 3.84
Operating Cash Flow Coverage Ratio
34.02 41.08 30.47 17.30 17.43
Operating Cash Flow to Sales Ratio
0.34 0.38 0.37 0.19 0.28
Free Cash Flow Yield
2.54%3.44%3.82%3.12%3.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.00 29.74 27.00 14.80 20.27
Price-to-Sales (P/S) Ratio
11.45 9.84 7.91 4.40 6.14
Price-to-Book (P/B) Ratio
7.35 6.06 5.41 3.89 5.17
Price-to-Free Cash Flow (P/FCF) Ratio
39.43 29.04 26.18 32.04 29.70
Price-to-Operating Cash Flow Ratio
33.76 25.73 21.44 22.69 21.96
Price-to-Earnings Growth (PEG) Ratio
80.87 1.57 -2.06 0.63 0.49
Price-to-Fair Value
7.35 6.06 5.41 3.89 5.17
Enterprise Value Multiple
23.38 19.12 17.54 9.48 13.08
Enterprise Value
13.46T 10.99T 8.34T 5.33T 5.89T
EV to EBITDA
23.38 19.12 17.54 9.48 13.08
EV to Sales
11.09 9.39 7.51 4.23 5.89
EV to Free Cash Flow
38.17 27.70 24.86 30.84 28.48
EV to Operating Cash Flow
32.68 24.55 20.35 21.84 21.06
Tangible Book Value Per Share
1.13K 1.14K 976.00 850.71 709.21
Shareholders’ Equity Per Share
1.15K 1.16K 988.07 866.00 722.57
Tax and Other Ratios
Effective Tax Rate
0.28 0.29 0.27 0.30 0.28
Revenue Per Share
737.50 711.34 675.52 766.02 608.07
Net Income Per Share
241.36 235.36 197.83 227.64 184.29
Tax Burden
0.72 0.71 0.73 0.70 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.15 0.16 0.12 0.14
SG&A to Revenue
0.00 0.00 0.00 0.02 0.03
Stock-Based Compensation to Revenue
0.00 <0.01 0.00 0.00 0.00
Income Quality
1.04 1.16 1.26 0.42 0.59
Currency in JPY